In this report, which primarily focused on inflammation in the gastrointestinal tract, GM-CSF−/− T cells induced less GVHD in the colon as evidenced by reduced colonoscopy and clinical scores, as well as increased overall survival. The gene discussed is CSF2; the disease is graft versus host disease.